Primer Santral Sinir Sistemi Lenfoması: Üç Olgu Sunumu

Cilt: 30 Sayı: 3 1 Eylül 2004
  • Meral Kurt
  • Sibel Kahraman Çetintaş
  • Candan Kartal
  • Nuray Canki
  • Günhan Berber Cebelli
  • Umut Kayışoğulları
  • Kayıhan Engin
PDF İndir
EN TR

Primary Central Nervous System Lymphoma: Report Of Three Cases

Öz

Primary central nervous system non-Hodgkin's lymphoma (PCNSL) is an uncommon tumor, representing 0.85-2.0 % of all primary brain tumors. PCNSL occurs more frequently in congenital and acquired im-munodeficiency states, especially in acquired immunodeficiency syndrome (AIDS). Patients with sporadic PCNLS without HIV infection and immunosupression have traditionally been treated with radiotherapy (RT). For nonimmunosuppression patients, whole brain irradiation (40 to 50 Gy) with or without a local boost to the primary tumor (60 to 65 Gy) is suggested. Despite high clinical and radiological response rate and effective palliation, the disease mostly recurs with a median survival fallowing RT alone only 10-18 months and few long-term survivors. Improved survival with the addition of chemotherapy (CT) to RT has been suggested; but combined modality therapy did not produce an overall survival advantage in multiple trials.

Anahtar Kelimeler

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Meral Kurt Bu kişi benim

Sibel Kahraman Çetintaş Bu kişi benim

Candan Kartal Bu kişi benim

Nuray Canki Bu kişi benim

Günhan Berber Cebelli Bu kişi benim

Umut Kayışoğulları Bu kişi benim

Kayıhan Engin Bu kişi benim

Yayımlanma Tarihi

1 Eylül 2004

Gönderilme Tarihi

1 Eylül 2004

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2004 Cilt: 30 Sayı: 3

Kaynak Göster

APA
Kurt, M., Kahraman Çetintaş, S., Kartal, C., Canki, N., Berber Cebelli, G., Kayışoğulları, U., & Engin, K. (2004). Primary Central Nervous System Lymphoma: Report Of Three Cases. Journal of Uludağ University Medical Faculty, 30(3), 227-231. https://izlik.org/JA36MP95YE
AMA
1.Kurt M, Kahraman Çetintaş S, Kartal C, vd. Primary Central Nervous System Lymphoma: Report Of Three Cases. Uludağ Tıp Derg. 2004;30(3):227-231. https://izlik.org/JA36MP95YE
Chicago
Kurt, Meral, Sibel Kahraman Çetintaş, Candan Kartal, vd. 2004. “Primary Central Nervous System Lymphoma: Report Of Three Cases”. Journal of Uludağ University Medical Faculty 30 (3): 227-31. https://izlik.org/JA36MP95YE.
EndNote
Kurt M, Kahraman Çetintaş S, Kartal C, Canki N, Berber Cebelli G, Kayışoğulları U, Engin K (01 Eylül 2004) Primary Central Nervous System Lymphoma: Report Of Three Cases. Journal of Uludağ University Medical Faculty 30 3 227–231.
IEEE
[1]M. Kurt vd., “Primary Central Nervous System Lymphoma: Report Of Three Cases”, Uludağ Tıp Derg, c. 30, sy 3, ss. 227–231, Eyl. 2004, [çevrimiçi]. Erişim adresi: https://izlik.org/JA36MP95YE
ISNAD
Kurt, Meral - Kahraman Çetintaş, Sibel - Kartal, Candan - Canki, Nuray - Berber Cebelli, Günhan - Kayışoğulları, Umut - Engin, Kayıhan. “Primary Central Nervous System Lymphoma: Report Of Three Cases”. Journal of Uludağ University Medical Faculty 30/3 (01 Eylül 2004): 227-231. https://izlik.org/JA36MP95YE.
JAMA
1.Kurt M, Kahraman Çetintaş S, Kartal C, Canki N, Berber Cebelli G, Kayışoğulları U, Engin K. Primary Central Nervous System Lymphoma: Report Of Three Cases. Uludağ Tıp Derg. 2004;30:227–231.
MLA
Kurt, Meral, vd. “Primary Central Nervous System Lymphoma: Report Of Three Cases”. Journal of Uludağ University Medical Faculty, c. 30, sy 3, Eylül 2004, ss. 227-31, https://izlik.org/JA36MP95YE.
Vancouver
1.Meral Kurt, Sibel Kahraman Çetintaş, Candan Kartal, Nuray Canki, Günhan Berber Cebelli, Umut Kayışoğulları, Kayıhan Engin. Primary Central Nervous System Lymphoma: Report Of Three Cases. Uludağ Tıp Derg [Internet]. 01 Eylül 2004;30(3):227-31. Erişim adresi: https://izlik.org/JA36MP95YE

ISSN: 1300-414X, e-ISSN: 2645-9027

Uludağ Üniversitesi Tıp Fakültesi Dergisi "Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License" ile lisanslanmaktadır.


Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

2023